ClinicalTrials.gg
Not yet recruitingNCT07148219EYP-VRUpdated Aug 29, 2025

EMBRACE YOUR POWER

An interventional study of Embrace Your Power: A VR Journey to Overcome Negative Emotions in Bullying, Distress and Bullying Victimisation, sponsored by University of Bucharest. Not yet recruiting at 1 site in Romania. Open to participants aged 10 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by University of Bucharest · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
10 Years to 14 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial is to test the effectiveness of an educational tool, based on virtual reality (VR), for preventing and combating bullying and for improving the emotional well-being of pre-adolescent students.

Participants will be allocated to one of two conditions:

  • (1) intervention group: Embrace your power intervention for combating bullying;
  • (2) waitlist (inactive control): the control group receives intervention after the study ends.

The intervention group will be compared to the control group in terms of peer aggression and victimization (bullying behaviors) and emotional symptoms.

Read the detailed description

This protocol outlines a cluster, parallel-group, exploratory, randomized controlled trial where participants are randomly allocated to one of the two groups: intervention or control.

  • The main objective is to implement and assess the effectiveness of the program for combating bullying through virtual reality. The program aims to reduce victimization and bullying behaviors (physical, verbal, and relational aggression) by applying the APRI tool as a result of participating in VR scenarios that simulate these situations and to reduce emotional difficulties and behavioral problems, as well as increase prosocial behavior.
  • The included classes will serve as the randomization units. Students aged between 10 and 14 years, (5th and 6th grades from middle schools) will participate in the study. The intervention will last 7 weeks, and the two groups will be assessed at (1) pre-intervention (baseline), (2) middle of the intervention (week 3 or 4), and (3) post-intervention. The data analysis will focus on improvement in outcomes between and within groups.
02

Conditions studied

  • Bullying
  • Distress
  • Bullying Victimisation

Browse trials for

Keywords

  • randomized controlled trial
  • bullying
  • virtual reality
  • distress
03

In context

Bullying

57 studies on the registry are indexed under Bullying; 9 are open to participants now.

This study's planned enrollment of 300 is above the median of 228 across 51 interventional studies indexed under Bullying.

Browse Bullying studies →

Lead sponsor

University of Bucharest is the lead sponsor of 11 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Students 5th and 6th grade
  • Students whose parents have given their consent and who have also agreed to participate in the program

Exclusion criteria

Exclusion Criteria:

  • Medical problems that have VR-based procedures as because they can induce dizziness, seizures, nausea:

    1. epilepsy
    2. presence of seizures
    3. severe motion sickness- vestibular disorders
    4. significant vision problems that would interfere with the use of the headset
    5. severe migraines triggered by exposure to screens
  • Neurodevelopmental disorders

    1. Autism spectrum disorder- level 3 of severity or sensory processing disorders
    2. ADHD, if hyperactivity would prevent the student from staying in the exercise for longer
  • Points a) and b) do not represent automatic exclusion criteria, because depending on the judgment of the school counselor, the parent and the teacher, it is possible that a participant will be able to complete the program.
  • Severe mental disorders: psychotic spectrum disorders, post-traumatic stress disorder, present suicidal ideation
  • If children have an extremely low level of literacy perceived by the teacher and counselor, and this aspect would prevent them from participating in the program.
  • Parallel participation in other bullying prevention programs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Intervention

    VR program for preventing and combating bullying

    Behavioral: Embrace Your Power: A VR Journey to Overcome Negative Emotions

  • No intervention
    Waitlist

    The control group receives the intervention after the study ends.

Interventions

  • BehavioralEmbrace Your Power: A VR Journey to Overcome Negative Emotions

    EYP-VR represents a virtual reality (VR) educational tool to combat bullying. Using Meta Quest 3 passthrough technology, the app combines real-world classroom elements with immersive virtual scenarios, enabling safe and interactive experiences that simulate bullying situations but that do not place students in the roles of victims or aggressors but heroes or protectors. The app guides participants through narrative episodes focused on building empathy, practicing assertiveness, and learning conflict resolution techniques. AI-driven characters dynamically respond to students' actions as they engage in puzzles, and sensory feedback (visual, auditory, and haptic) reinforces key socio-emotional learning outcomes. The program will take place in classrooms during instructional hours. Each session will end with a feedback phase so that the school counselor can manage any issues that interest them.

06

What researchers measure

Primary outcomes

  1. Bullying behaviors

    Bullying behaviors will be measured using the Adolescent Peer Relations Instrument (APRI) -C2. The instrument encompasses bullying victimization, perpetration, and bystander experiences. APRI represents a psychometric tool that measures teens' experiences with bullying and victimization through 36 items rated on a 6-point Likert scale (1= never, 6= every day).

    Time frame: Pre-intervention (baseline), middle intervention, post-intervention (week 7)

Secondary outcomes

  1. Emotional symptoms

    Emotional distress will be assessed using the Emotional Symptoms subscale from the Strengths and Difficulties Questionnaire - SDQ (Romanian self-report). The instrument consists of 25 items, and 5 items are representative of emotional symptoms. Items are rated on a 3-point Likert scale where 1= untrue and 3= certainly true.

    Time frame: Pre-intervention (baseline), middle intervention, post-intervention (week 7)

Other outcomes

  1. Strengths and Difficulties

    The other subscales from the Strengths and Difficulties Questionnaire (SDQ) will be used to measure conduct problems (5 items), hyperactivity/inattention (5 items), peer relationship problems (5 items) and prosocial behavior (5 items). Items are measured on a 3-point Likert scale where 1= untrue and 5= certainly true.

    Time frame: Pre-intervention (baseline), middle intervention, post-intervention (week 7)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2025; primary completion for Sep 2026, 11 months later.

Of 36 non-industry interventional studies with no phase under Bullying, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 18. This study's planned 11 months is close to that.

Counting every sponsor, half of 40 studies reached it within 11 months; a quarter within 4 and three quarters within 20.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2025
First posted
Aug 29, 2025
StartEst.
Oct 2025
Primary completionEst.
Sep 30, 2026
CompletionEst.
Jan 2027
Last update
Aug 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07148219
Lead sponsor
University of Bucharest
Collaborators
Remnant Dream SRL
Responsible party
Cezar Giosan (Cezar Giosan, PhD, University of Bucharest) — Principal investigator
First posted
Aug 29, 2025
Start date
Oct 2025 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Aug 29, 2025

Study contacts

Cezar Giosan, PhD
Contact
giosan@outlook.com
+40730908050

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion